FDA Public Workshop on Development of Anti-Bacterial Drugs (Aug. 2-3, 2010)
This post was written by Paul Sheives.
FDA is hosting a public workshop and seeking input from industry, health care providers, and researchers on issues affecting the design and conduct of clinical studies for anti-bacterial drugs. The primary focus of the workshop is the design and conduct of non-inferiority clinical studies, which are frequently used in the context of evaluating anti-bacterial drugs. The meeting will be held on August 2-3, 2010, in Silver Spring, MD.
